Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07335419 · ClinicalTrials.gov registry record · Phase 1
A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine)
A Phase 1 study of Healthy Adult Participants, sponsored by Pfizer.
- Active
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT07335419 is a Phase 1 study of Healthy Adult Participants that is active but no longer recruiting, run by Pfizer. The registered enrollment target is 12 participants, below the 77-participant average among 4 other Healthy Adult Participants trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07335419, a Phase 1 study of Healthy Adult Participants, is active but no longer recruiting, sponsored by Pfizer.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to learn how itraconazole changes how the body processes the study medicine called PF-07248144. The study will also look at the safety, tolerability, and how PF-07248144 is changed and removed from the body after taking PF-07248144 alone compared to when it is taken with itraconazole. Itraconazole can change how your body processes some medications so it may change the body's processing of PF-07248144. Multiple blood samples will be collected after each dose of PF-07248144 to determine how much PF-07248144 is in the blood at different times. This will help characterize the pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it) of PF-07248144 alone and when taken with itraconazole.
Conditions Studied
Interventions
- DRUG Itraconazole
- DRUG PF-07248144
Study Locations (1)
Connecticut
- Pfizer Clinical Research Unit - New Haven - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-01-02 |
| Est. Completion | 2026-03-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07335419
The ClinicalTrials.gov registry entry for NCT07335419 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 77-participant average among 4 other Healthy Adult Participants trials with a reported enrollment target (84% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Adult Participants appearing as the primary indexed condition, and to 2 interventions - of which Itraconazole is the first listed.
NCT07335419 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT07335419 about?
NCT07335419 is a clinical study titled "A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine)". The purpose of the study is to learn how itraconazole changes how the body processes the study medicine called PF-07248144. The study will also look at the safety, tolerability, and how PF-07248144 is changed and removed from the body after taking PF-07248144 alone compared to when it is taken with ...
What is the current status of trial NCT07335419?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2026-01-02. Estimated completion is 2026-03-21.
What conditions does trial NCT07335419 study?
This clinical trial studies the following conditions: Healthy Adult Participants.
What interventions are being tested in trial NCT07335419?
The interventions under investigation include: Itraconazole (DRUG), PF-07248144 (DRUG).
Who is sponsoring clinical trial NCT07335419?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07335419 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adult Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants
RECRUITING · Phase 1
-
A Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11
RECRUITING · Phase 1
-
Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects
COMPLETED · Phase 1
-
Evaluation of [18F]GATT-44 for Positron Emission Tomography Imaging of the GABA Transporter-1
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.